Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Blázquez, Daniel ^a   Ramos Amador, José Tomás ^b   Saínz, Talía ^c   Mellado, María José ^c   García Ascaso, Marta ^d   De José, María Isabel ^c   Rojo, Pablo ^a   Navarro, María Luisa ^e   Muñoz Fernández, María ángeles ^f   Saavedra, Jesús ^e   Roa, Miguel Angel ^g   Jiménez, Santiago ^f   Beceiro, José ^h   Prieto, Luis ⁱ   Hortelano, Milagros García ^b   González Tomé, María Isabel ^a  

^a 12 de Octubre University Hospital Complutense University Instituto de Investigación Hospital 12 de Octubre Pediatric Infectious Diseases Unit ^*  (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL DE MÓSTOLES   (Spain)

^h HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Adolescents; HIV; Insulin resistance; Lipid abnormalities; Waist

Indexed keywords

ANTIRETROVIRUS AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISORDERS OF LIPID METABOLISM; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PATIENT COMPLIANCE; PERINATAL INFECTION; PREVALENCE; PROSPECTIVE STUDY; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST CIRCUMFERENCE Z SCORE; YOUNG ADULT; DYSLIPIDEMIAS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; LIPID METABOLISM; METABOLISM; STATISTICAL MODEL; VERTICAL TRANSMISSION;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD GLUCOSE; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INSULIN RESISTANCE; LIPID METABOLISM; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PREVALENCE; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84926379619     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0853-8     Document Type: Article

References (32)

1. Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, et al. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS. 2009;23:661-72.
2. Dapena M, Jiménez B, Noguera-Julian A, Soler-Palacín P, Fortuny C, Lahoz R, et al. Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease. J Pediatr Endocrinol Metab. 2012;25:529-35.
3. Miller TL, Orav EJ, Lipshultz SE, Arheart KL, Duggan C, Weinberg GA, et al. Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr. 2008;153:491-7.
4. Hazra R, Hance LF, Monteiro JP, Ruz NP, Machado DM, Saavedra M, et al. Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children. Pediatr Infect Dis J. 2013;32:757-9.
5. Berenson G, Srinivasan S. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650-6.
6. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
7. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179-93.
8. Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake M, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation. 2005;112:103-9.
9. McComsey GA, O'Riordan M, Hazen SL, El-Bejjani D, Bhatt S, Brennan ML, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS. 2007;21:921-7.
10. Sainz T, Alvarez-Fuente M, Navarro ML, Díaz L, Rojo P, Blázquez D, et al. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH study. J Acquir Immune Defic Syndr. 2014;65:42-9.
11. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48-62.
12. Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP. Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism. 1991;40:651-6.
13. Båvenholm P, Karpe F, Proudler A, Tornvall P, Crook D, Hamsten A. Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype. Metabolism. 1995;44:1481-8.
14. Carrascosa Lezcano A, Fernández García JM, Fernández Ramos C, Ferrández Longás A, López-Siguero JP, Sánchez González E, et al. Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood. An Pediatr (Barc). 2008;68:552-69.
15. Ruiz JR, Ortega FB, Tresaco B, Wrnberg J, Mesa JL, González-Gross M, et al. Serum lipids, body mass index and waist circumference during pubertal development in Spanish adolescents: the AVENA Study. Horm Metab Res. 2006;38:832-7.
16. De Jose MI, Jiménez De Ory S, Espiau M, Fortuny C, Navarro ML, Soler-Palacín P, et al. A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe). BMC Infect Dis. 2013;13:2.
17. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl1):S8-16.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
19. García Cuartero B, García Lacalle C, Jiménez Lobo C, González Vergaz A, Calvo Rey C, Alcázar Villar MJ, et al. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An Pediatr (Barc). 2007;66:481-90.
20. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198-208.
21. Dos Reis LC, de Carvalho Rondó PH, de Sousa Marques HH, de Andrade SB. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents. Trans R Soc Trop Med Hyg. 2011;105:197-203.
22. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18:1443-51.
23. Garcés C, de Oya M. Cardiovascular risk factors in children. Main findings of the Four Provinces study. Rev Esp Cardiol. 2007;60:517-24.
24. Lee B, Aurpibul L, Sirisanthana V, Mangklabruks A, Sirisanthana T, Puthanakit T. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand. HIV Med. 2009;10:72-8.
25. Rosso R, Parodi A, Annunzio G, Ginocchio F, Nicolini L, Torrisi C, et al. Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol. 2007;157:655-9.
26. Geffner ME, Patel K, Miller TL, Hazra R, Silio M, Van Dyke RB, et al. Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr. 2011;76:386-91.
27. Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation. 2010;121:237-44.
28. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105-20.
29. Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Berenson GS, Bouchard C. Disease Risk Factors in a Biracial Sample of Children and Adolescents. Pediatrics. 2004;114:e198.
30. Janiszewski PM, Ross R, Despres J-P, Lemieux I, Orlando G, Carli F, et al. Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study. PLoS One. 2011;6:e25032.
31. Dimock D, Thomas V, Cushing A, Purdy J. Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metabolism. 2011;60:874-80.
32. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603-8.